MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS
<p>The mechanism of myocardial damage in diabetes mellitus is considered. The pathogenesis of myocardial fibrosis, leading to diabetic cardiomyopathy, is described in details. Management tactics aimed at the prevention of heart failure in patients with diabetes is proposed.</p>
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Stolichnaya Izdatelskaya Kompaniya
2015-09-01
|
| Series: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
| Subjects: | |
| Online Access: | http://www.rpcardio.ru/jour/article/view/45 |
| id |
doaj-f26482ef96eb453199370b0f3350a423 |
|---|---|
| record_format |
Article |
| spelling |
doaj-f26482ef96eb453199370b0f3350a4232020-11-25T01:56:40ZengStolichnaya Izdatelskaya KompaniyaRacionalʹnaâ Farmakoterapiâ v Kardiologii1819-64462225-36532015-09-0191626510.1234/1819-6446-2013-1-62-6544MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUSO. M. Drapkina0B. B. Gegenava1Первый Московский государственный медицинский университет им. И.М.СеченоваПервый Московский государственный медицинский университет им. И.М.Сеченова<p>The mechanism of myocardial damage in diabetes mellitus is considered. The pathogenesis of myocardial fibrosis, leading to diabetic cardiomyopathy, is described in details. Management tactics aimed at the prevention of heart failure in patients with diabetes is proposed.</p>http://www.rpcardio.ru/jour/article/view/45сахарный диабетгипергликемияинсулинорезистентностьатеросклерозфиброздиабетическая кардиомиопатиястатиныбета-блокаторыингибиторы АПФтиазолидиндионысердечная недостаточность |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
O. M. Drapkina B. B. Gegenava |
| spellingShingle |
O. M. Drapkina B. B. Gegenava MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS Racionalʹnaâ Farmakoterapiâ v Kardiologii сахарный диабет гипергликемия инсулинорезистентность атеросклероз фиброз диабетическая кардиомиопатия статины бета-блокаторы ингибиторы АПФ тиазолидиндионы сердечная недостаточность |
| author_facet |
O. M. Drapkina B. B. Gegenava |
| author_sort |
O. M. Drapkina |
| title |
MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS |
| title_short |
MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS |
| title_full |
MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS |
| title_fullStr |
MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS |
| title_full_unstemmed |
MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS |
| title_sort |
myocardial fibrosis in patients with diabetes mellitus |
| publisher |
Stolichnaya Izdatelskaya Kompaniya |
| series |
Racionalʹnaâ Farmakoterapiâ v Kardiologii |
| issn |
1819-6446 2225-3653 |
| publishDate |
2015-09-01 |
| description |
<p>The mechanism of myocardial damage in diabetes mellitus is considered. The pathogenesis of myocardial fibrosis, leading to diabetic cardiomyopathy, is described in details. Management tactics aimed at the prevention of heart failure in patients with diabetes is proposed.</p> |
| topic |
сахарный диабет гипергликемия инсулинорезистентность атеросклероз фиброз диабетическая кардиомиопатия статины бета-блокаторы ингибиторы АПФ тиазолидиндионы сердечная недостаточность |
| url |
http://www.rpcardio.ru/jour/article/view/45 |
| work_keys_str_mv |
AT omdrapkina myocardialfibrosisinpatientswithdiabetesmellitus AT bbgegenava myocardialfibrosisinpatientswithdiabetesmellitus |
| _version_ |
1724978718024138752 |